Rose Research Center, LLC

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Efficacy and Tolerability of Combination Varenicline With Hydroxyzine as a Potential Smoking Cessation Treatment

Phase 4

Completed

Conditions: Stress
Sleep Disturbance
Smoking Cessation
Nausea

Interventions: Drug: Varenicline Pill
Drug: Hydroxyzine Pill

First Posted Date: 2019-12-05

Last Posted Date: 2023-03-03

Lead Sponsor: Rose Research Center, LLC

Target Recruit Count: 26

Registration Number: NCT04188106

Locations: 🇺🇸
Rose Research Center, Raleigh, North Carolina, United States

Assisting Smokers to Switch to a JUUL E-Cigarette by Devaluing Combustible Cigarettes

Phase 3

Conditions: Smoking Cessation
E-Cig Use
Harm Reduction
Tobacco Use Cessation
Cigarette Smoking
Tobacco Dependence

Interventions: Other: JUUL

First Posted Date: 2019-12-05

Last Posted Date: 2020-07-23

Lead Sponsor: Rose Research Center, LLC

Target Recruit Count: 50

Registration Number: NCT04188197

Locations: 🇺🇸
Rose Research Center, Raleigh, North Carolina, United States

Abuse Liability of Reduced Nicotine Content Cigarettes in the Context of Concurrent E-Cigarette Use

Phase 2

Completed

Conditions: Cigarette Smoking
Nicotine Addiction

Interventions: Drug: Smoking research cigarettes with e-cigarette
Drug: Nicotine discrimination thresholds

First Posted Date: 2016-08-17

Last Posted Date: 2022-01-14

Lead Sponsor: Rose Research Center, LLC

Target Recruit Count: 150

Registration Number: NCT02870218

Locations: 🇺🇸
Rose Research Center, Raleigh, North Carolina, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy